Fulgent Genetics (FLGT) Non-Current Assets (2016 - 2025)
Fulgent Genetics (FLGT) has disclosed Non-Current Assets for 11 consecutive years, with $663.0 million as the latest value for Q4 2025.
- Quarterly Non-Current Assets fell 23.47% to $663.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Dec 2025, down 15.07% year-over-year, with the annual reading at $663.0 million for FY2025, 23.47% down from the prior year.
- Non-Current Assets hit $663.0 million in Q4 2025 for Fulgent Genetics, down from $707.2 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $907.2 million in Q3 2024 to a low of $339.9 million in Q1 2021.
- Historically, Non-Current Assets has averaged $723.6 million across 5 years, with a median of $749.3 million in 2023.
- Biggest five-year swings in Non-Current Assets: skyrocketed 1025.49% in 2021 and later dropped 23.47% in 2025.
- Year by year, Non-Current Assets stood at $666.8 million in 2021, then fell by 0.27% to $664.9 million in 2022, then grew by 9.4% to $727.5 million in 2023, then rose by 19.09% to $866.4 million in 2024, then decreased by 23.47% to $663.0 million in 2025.
- Business Quant data shows Non-Current Assets for FLGT at $663.0 million in Q4 2025, $707.2 million in Q3 2025, and $771.1 million in Q2 2025.